Market closed · Next open: Monday 9:30 AM ET
Last update: Aug 28, 2026, 6:10 PM ET
Hinge Health, Inc.
$87.35 5.92% today
Market Closed

Why Hinge Health, Inc. (HNGE) stock moved

Updated Aug 29, 2026

Hinge Health, Inc. (HNGE) shares tumbled 5.9% to $87.35 as of August 29, 2026, a significant decline from the prior close of $92.85. BestStocks flagged the session as a major change for HNGE. The move is tied to price move down. Below, we break down what changed for HNGE, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

HNGE fell 5.9% to $87.35

HNGE tumbled 5.9% in its latest session, moving from $92.85 to $87.35.

Material / EarningsMedium confidence
Rel. volume
1.2×
Normal
Vs peers
No comparable peers
Market cap
$6.8B
New York Stock Exchange
Analyst target
$97
+11.6% vs price
Price chart
Jul 29 – Aug 28
EVVFVEEEEVV$74$83$93Jul 29Aug 6Aug 13Aug 21Aug 28
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Hinge Health, Inc. investors

For Hinge Health, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Hinge Health, Inc. (HNGE) moved +1.88% from $89.88 to $91.57 on 2026-08-10; Hinge Health, Inc. (HNGE) moved +11.13% from $80.38 to $89.33 on 2026-08-07. Weighing against that: Material negative event; Sharp 5.9% decline — elevated risk. Wall Street's consensus price target sits at $97.46, implying +11.6% upside from $87.35. BestStocks rates the overall signal quality medium (60/100). With earnings roughly 66 days out, the next report is the most likely near-term test of the move.

HNGE price reaction

HNGE last traded at $87.35, down $5.50 (-5.92%) from the previous close of $92.85. The session traded on 1.2× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $74.06 and $92.85, and it currently sits about 71% of the way up that band.

Bullish and bearish analyst opinions on Hinge Health, Inc. (HNGE)

The consensus analyst price target on Hinge Health, Inc. (HNGE) is $97.46, 11.6% above the recent $87.35. Over the past 90 days analysts logged 0 upgrades, 23 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HNGE line up.

The bullish case

  • Wall Street's consensus price target of $97.46 implies +11.6% upside from $87.35.
  • The Street's most bullish target is $125.00 (+43.1%).
  • Hinge Health, Inc. (HNGE) moved +1.88% from $89.88 to $91.57 on 2026-08-10.

The bearish case

  • The most bearish analyst target is $65.00 (-25.6%).
  • Material negative event.
  • Sharp 5.9% decline — elevated risk.
  • Hinge Health, Inc. (HNGE) moved -6.25% from $84.35 to $79.08 on 2026-07-22.
Bull vs bear balanceBearish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Aug 29, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $97+11.6%
= 23 maintains
Truist Securities maintained Buy · 2026-08-11
SEC filings watch
10-Q2026-08-06
Quarterly financial results
medium
8-K2026-08-04
Material event — review for impact
high
8-K2026-06-09
Material event — review for impact
high
8-K2026-06-04
Material event — review for impact
high
Peer context
HNGE-5.9%

Previous notable changes for HNGE

Valuation2026-08-27+2.6%via Yahoo Finance
Hinge Health stock rose 2.15% to $92.45, extending gains from recent positive catalysts. The digital musculoskeletal health company reported strong Q2 revenue of $212.82 million (above consensus) and raised full-year guidance to $223–$225 million for Q3, while announcing a $105 million acquisition of Cylinder Health to expand into gastrointestinal care. Major analysts including Needham, Citizens JMP, and KeyBanc subsequently raised their price targets following the earnings beat and strategic acquisition announcement.
Valuation2026-08-26+0.7%via Yahoo Finance
Hinge Health is rallying +2.18% to $91.83, sustained by momentum from its August blowout Q2 earnings (revenue +53% YoY to $212.8M, beating consensus) and management's full-year guidance raise, per investors.com and finance.yahoo.com. The digital musculoskeletal care provider has also fueled investor enthusiasm with expansion into migraine treatment via the Enzo wearable and a definitive agreement to acquire Cylinder Health for gastrointestinal care entry, alongside multiple analyst price-target upgrades toward the $85–$110 range. Volume of 441,966 shares is tracking at 0.74x the historical average, consistent with typical mid-session trading.
Material / Earnings2026-08-21+3.3%
Hinge Health, Inc. (HNGE) moved +3.17% from $85.70 to $88.42 on 2026-08-21. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move was not driven by unusual trading activity.
Material / Earnings2026-08-20-3.2%
Hinge Health, Inc. (HNGE) moved -2.96% from $88.23 to $85.62 on 2026-08-20. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average at 1.2x, indicating no unusual trading activity.
Upcoming catalysts & outlook
Next earnings
2026-11-03 (est.)
in 66 days
10-Q Filing (est.)
2026-11-05
Medium impact
Thesis shift
Bearish Shift
bearish signal
Risk level
High
from change events

Frequently asked questions about HNGE

Why did Hinge Health, Inc. (HNGE) stock move?

HNGE tumbled 5.9% to $87.35. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did HNGE stock fall?

HNGE lost 5.92% ($5.50) versus the prior close of $92.85, last trading at $87.35 on 1.2× average volume.

When is Hinge Health, Inc.'s next earnings date?

HNGE's next earnings report is estimated for 2026-11-03 — about 66 days away.

What is the analyst price target for HNGE?

The consensus analyst price target for HNGE is $97.46, about 11.6% above the current $87.35. Over the past 90 days, analysts recorded 0 upgrades, 23 maintains, and 0 downgrades.

How BestStocks tracks HNGE

This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 20 tracked change events for HNGE, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 29, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.